IL193819A0 - Concentrate of chikungunya-specific immunoglobulins as medicine - Google Patents

Concentrate of chikungunya-specific immunoglobulins as medicine

Info

Publication number
IL193819A0
IL193819A0 IL193819A IL19381908A IL193819A0 IL 193819 A0 IL193819 A0 IL 193819A0 IL 193819 A IL193819 A IL 193819A IL 19381908 A IL19381908 A IL 19381908A IL 193819 A0 IL193819 A0 IL 193819A0
Authority
IL
Israel
Prior art keywords
chikungunya
concentrate
medicine
specific immunoglobulins
immunoglobulins
Prior art date
Application number
IL193819A
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Publication of IL193819A0 publication Critical patent/IL193819A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL193819A 2006-03-31 2008-09-01 Concentrate of chikungunya-specific immunoglobulins as medicine IL193819A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602802A FR2899111B1 (en) 2006-03-31 2006-03-31 CONCENTRATE OF CHIKUNGUNYA SPECIFIC IMMUNOGLOBULINS AS A MEDICINAL PRODUCT.
PCT/FR2007/000561 WO2007118987A1 (en) 2006-03-31 2007-04-02 Concentrate of chikungunya-specific immunoglobulins as medicine

Publications (1)

Publication Number Publication Date
IL193819A0 true IL193819A0 (en) 2011-08-01

Family

ID=37433721

Family Applications (1)

Application Number Title Priority Date Filing Date
IL193819A IL193819A0 (en) 2006-03-31 2008-09-01 Concentrate of chikungunya-specific immunoglobulins as medicine

Country Status (11)

Country Link
US (1) US20080219969A1 (en)
EP (1) EP2004233A1 (en)
JP (1) JP2009531401A (en)
KR (1) KR20080108556A (en)
CN (1) CN101410138A (en)
AU (1) AU2007239415A1 (en)
BR (1) BRPI0709448A2 (en)
CA (1) CA2647506A1 (en)
FR (1) FR2899111B1 (en)
IL (1) IL193819A0 (en)
WO (1) WO2007118987A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2374816B1 (en) * 2010-04-07 2016-09-28 Agency For Science, Technology And Research Binding molecules against Chikungunya virus and uses thereof
WO2011124635A1 (en) 2010-04-07 2011-10-13 Humalys Binding molecules against chikungunya virus and uses thereof
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814433A (en) * 1987-09-16 1989-03-21 Miles Inc. Method for obtaining a papain-free antibody fragment preparation
JPH06256215A (en) * 1993-03-09 1994-09-13 Fuji Photo Film Co Ltd Preparation of multi-specific f(ab')3
JPH1059999A (en) * 1996-08-22 1998-03-03 Kanto Chem Co Inc Separation and purification of antibody
JPH1060000A (en) * 1996-08-22 1998-03-03 Kanto Chem Co Inc Purification of antibody
EP0835880A1 (en) * 1996-10-14 1998-04-15 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Process for producing an IgM preparation for intravenous administration
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
ES2527915T3 (en) * 1998-06-09 2015-02-02 Csl Behring Ag Liquid immunoglobulin G (IgG) product
JP2004518651A (en) * 2000-12-15 2004-06-24 グラクソ　グループ　リミテッド Therapeutic compounds
FR2824568B1 (en) * 2001-05-11 2004-04-09 Lab Francais Du Fractionnement PROCESS FOR THE PREPARATION OF HUMAN IMMUNOGLOBULIN CONCENTRATES FOR THERAPEUTIC USE
US20030180287A1 (en) * 2002-02-27 2003-09-25 Immunex Corporation Polypeptide formulation
FR2899112B1 (en) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement CONCENTRATE OF IMMUNOGLOBULINS AND F (AB) '2 AND / OR FAB FRAGMENTS SPECIFIC OF ARBOVIRUS AS A MEDICAMENT.

Also Published As

Publication number Publication date
CN101410138A (en) 2009-04-15
KR20080108556A (en) 2008-12-15
US20080219969A1 (en) 2008-09-11
FR2899111A1 (en) 2007-10-05
WO2007118987A1 (en) 2007-10-25
FR2899111B1 (en) 2010-09-03
JP2009531401A (en) 2009-09-03
AU2007239415A1 (en) 2007-10-25
EP2004233A1 (en) 2008-12-24
CA2647506A1 (en) 2007-10-25
BRPI0709448A2 (en) 2011-07-12

Similar Documents

Publication Publication Date Title
HK1247531A1 (en) Human milk compositions
EP2068864A4 (en) Therapeutic uses of urolithins
HK1141013A1 (en) Process for the preparation of certain substituted sulfilimines
HK1139956A1 (en) Novel anti-cd38 antibodies for the treatment of cancer -cd38
EP2191856A4 (en) Blood purifier
GB0600488D0 (en) Immunoglobulins
IL206478A0 (en) Processes for the preparation and purification of paliperidone palmitate
IL201449A0 (en) Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
EP1998811A4 (en) Eimmunotherapy for immune suppressed patients
HK1128237A1 (en) Further medical uses of antisecretory protein
ZA200905468B (en) Therapeutical uses of eslicarbazepine
IL196602A0 (en) Processes for the preparation of montelukast
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
HK1134911A1 (en) Medicament for the treatment of endometriosis
HUP0700756A2 (en) Process for the preparation of pharmaceutical intermediers
EP2134368A4 (en) Homeopathic medicament useful for immunomodulation
IL193819A0 (en) Concentrate of chikungunya-specific immunoglobulins as medicine
EP2157089A4 (en) The therapeutic uses of imidazol-5-carboxylic acid derivatives
GB0723100D0 (en) Treatment of HFnEF
DK2182007T3 (en) Process for the preparation of human G-CSF
GB0618060D0 (en) Treatment of polyamides
ZA200905300B (en) Medicament for the treatment of endometriosis
IL193959A0 (en) Use of caspases for the preparation of medicaments
GB0602857D0 (en) The treatment of sialorrhoea
GB0602855D0 (en) The Treatment Of Sialorrhoea